Healthcare -
Biotechnology - NASDAQ - US
$ 7.45
-2.24 %
$ 1.21 B
Market Cap
2.54
P/E
NVAX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NVAX - Novavax, Inc.
261 M
LAST VALUE
-10.46%
2 YEAR CAGR
21.51%
5 YEAR CAGR
9.04%
10 YEAR CAGR